A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

June 16, 2016

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

TAK-788

TAK-788 capsules.

Trial Locations (62)

100

National Taiwan University Hospital, Taipei

407

Taichung Veterans General Hospital, Taichung

640

National Taiwan University Hospital - YunLin Branch, Douliu

10065

Memorial Sloan Kettering Cancer Center, New York

13620

Seoul National University Bundang Hospital, Seongnam-si

14165

HELIOS Klinikum Emil von Behring, Berlin

15006

Complejo Hospitalario Universitario A Coruna, A Coruña

20141

Istituto Di Ricovero E Cura A Carattere Scientifico - Istituto Europeo Di Oncologia, Milan

22031

Virginia Cancer Specialists - Fairfax Office, Fairfax

22908

University of Virginia Cancer Center, Charlottesville

28203

Levine Cancer Institute, Charlotte

28204

Carolinas Healthcare System, Charlotte

30322

Winship Cancer Institute, Atlanta

32804

AdventHealth Orlando, Orlando

35209

Brookwood Medical Center, Birmingham

37203

SCRI - Tennessee Oncology - Nashville - Centennial, Nashville

37232

University of Virginia Cancer Center, Nashville

37916

Thompson Oncology Group - Knoxville - Downtown, Knoxville

43126

Azienda Ospedaliero Universitaria di Parma, Parma

46260

Investigative Clinical Research - Indiana, Indianapolis

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

60637

The University of Chicago Medicine, Chicago

63110

Siteman Cancer Center - Washington University Medical Campus, St Louis

69126

Thoraxklinik Heidelberg, Heidelberg

70403

National Cheng Kung University Hospital, Tainan City

73102

Hightower Clinical, Oklahoma City

77030

The University of Texas MD Anderson Cancer Center, Houston

77090

Lumi Research, Houston

80045

University of Colorado Cancer Center, Aurora

85234

Banner MD Anderson Cancer Center, Gilbert

85745

The Oncology Institute of Hope and Innovation - West Tucson, Tucson

90603

The Oncology Institute of Hope and Innovation, Whittier

90720

Cancer and Blood Specialty Clinic, Los Alamitos

90813

Pacific Shores Medical Group-Long Beach Elm, Long Beach

91010

City of Hope Comprehensive Cancer Center - Duarte, Duarte

92093

University of California San Diego Moores Cancer Center, La Jolla

92708

Compassionate Cancer Care - Fountain Valley, Fountain Valley

92868

University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange

93405

SLO Oncology and Hematology Health Center, San Luis Obispo

94305

Stanford Cancer Center - Palo Alto, Palo Alto

97239

Oregon Health and Science University, Portland

98104

Swedish Cancer Institute, Seattle

100036

Peking University Cancer Hospital/Beijing Cancer Hospital, Beijing

101149

Beijing Chest Hospital, Beijing

200433

Shanghai Pulmonary Hospital, Shanghai

310003

The First Affiliated Hospital, Zhejiang University, Hangzhou

430079

Hubei Cancer Hospital, Wuhan

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

07960

Atlantic Health - Morristown Medical Center, Morristown

277-8577

National Cancer Center Hospital East, Kashiwa

830-0011

Kurume University Hospital, Kurume-shi

980-0873

Sendai Kousei Hospital, Sendai

589-8511

Kindai University Hospital, Ōsaka-sayama

00674

In Situ Global Clinical Trials Network, Manatí

03080

Seoul National University Hospital, Seoul

03722

Severance Hospital, Seoul

05505

Asan Medical Center, Seoul

08035

Hospital Universitari Vall d'Hebron, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY